(Q51722809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Susanne Vrtala

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

V Mahler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

T L Diepgen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

R Suck

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

O Cromwell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

H Fiebig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

A Hartl

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

J Thalhamer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

G Schuler

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

D Kraft

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

R Valenta

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Allergy

17 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

115-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

From allergen structure to new forms of allergen-specific immunotherapy

17 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Genetically engineered plant allergens with reduced anaphylactic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

High-level expression and purification of the major birch pollen allergen, Bet v 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Modulation of IgE-binding properties of tree pollen allergens by site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2004.01857.X

10.1111/J.1365-2222.2004.01857.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14720271%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference